These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis. Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911 [TBL] [Abstract][Full Text] [Related]
23. Pathological findings in rats with experimental allergic encephalomyelitis. Dong M; Liu R; Guo L; Li C; Tan G APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994 [TBL] [Abstract][Full Text] [Related]
24. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis. Muri L; Leppert D; Grandgirard D; Leib SL Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218 [TBL] [Abstract][Full Text] [Related]
25. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis. Can Demirdöğen B Med Hypotheses; 2019 Jul; 128():25-27. PubMed ID: 31203904 [TBL] [Abstract][Full Text] [Related]
26. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Ziemssen T; Ziemssen F Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612 [TBL] [Abstract][Full Text] [Related]
27. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus). 't Hart BA; Massacesi L J Neuropathol Exp Neurol; 2009 Apr; 68(4):341-55. PubMed ID: 19337065 [TBL] [Abstract][Full Text] [Related]
28. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis. Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039 [TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495 [TBL] [Abstract][Full Text] [Related]
30. [Disruption of the blood-brain barrier in inflammatory neurological diseases]. Shimizu F; Kanda T Brain Nerve; 2013 Feb; 65(2):165-76. PubMed ID: 23399674 [TBL] [Abstract][Full Text] [Related]
31. Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis. Hamid KM; Mirshafiey A Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):1-12. PubMed ID: 26996106 [TBL] [Abstract][Full Text] [Related]
32. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Tham E; Gielen AW; Khademi M; Martin C; Piehl F Scand J Immunol; 2006 Dec; 64(6):609-22. PubMed ID: 17083617 [TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related]
34. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis. Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787 [TBL] [Abstract][Full Text] [Related]
35. Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis. Shiryaev SA; Remacle AG; Savinov AY; Chernov AV; Cieplak P; Radichev IA; Williams R; Shiryaeva TN; Gawlik K; Postnova TI; Ratnikov BI; Eroshkin AM; Motamedchaboki K; Smith JW; Strongin AY J Biol Chem; 2009 Oct; 284(44):30615-26. PubMed ID: 19726693 [TBL] [Abstract][Full Text] [Related]